To date, Philadelphia has received 2,625 doses of the vaccine that was originally designed to prevent smallpox and has shown to be effective against monkeypox. More than half of that supply –1,613 doses – have already been administered to high-risk residents.
Another 690 doses have been distributed to community health providers and clinics, which have administered vaccines to existing patients at high risk of contracting the virus.
“Given the widespread desire for access to monkeypox vaccine, this type of information will provide better insight into numbers of cases and available doses during any given week and help explain why it may be so difficult to secure a dose,” said health department officials in a statement.
Philadelphia expects to receive another 6,020 vaccine doses from the federal government between now and the fall. Those will be divided into three shipments, the first of which will be about 2,420 doses.